O ran argymhellion NICE, byddwn yn cymryd cam pellach. Bydd disgwyl i fyrddau iechyd nawr gyflwyno meddyginiaethau sy'n cael eu hargymell gan NICE wrth iddynt gyhoeddi'r canllawiau terfynol am y tro cyntaf, yn hytrach nag aros am y canllawiau Arfarnu Technoleg terfynol sy'n cael eu cyhoeddi ar ôl y cyfnod apêl.
In respect of NICE recommendations we will go even further, health boards will now be expected to introduce medicines recommended by NICE at the first publication of the final guidance, rather than waiting for the final Technology Appraisal guidance published after the appeal period.